Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Galai

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Antiviral Therapy|July 1, 1997
Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion StudyG Rezza, N Galai, P Pezzotti, et al.
BMJ (Clinical Research Ed.)|September 7, 1996
Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study GroupP Pezzotti, A N Phillips, M Dorrucci, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
An evaluation of assumptions underlying respondent-driven sampling and the social contexts of sexual and gender minority youth participating in HIV clinical trials in the United StatesA L Wirtz, J Iyer, D Brooks, et al.
Neurology|January 1, 1997
HIV infection and cognition in intravenous drug users: long-term follow-upO A Selnes, N Galai, J C McArthur, et al.
Archives of Internal Medicine|October 23, 1995
Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infectionW T Caiaffa, N M Graham, N Galai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 20, 2007
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panelsB Sarov, L Novack, N Galai, et al.
Addiction (Abingdon, England)|May 17, 2007
Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug usersD Vlahov, P O'Driscoll, S H Mehta, et al.
Archives of Internal Medicine|June 14, 2001
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspectiveS A Strathdee, N Galai, M Safaiean, et al.
Sidahora : Un Proyecto Del Departamento De Publicaciones Del PWA Coalition, NY|October 30, 2001
[The difference between men and women drug users in seroconversion risk factors]S A Strathdee, N Galai, M Safaiean, et al.
European Journal of Clinical Pharmacology|January 5, 2002
The prescription pattern of oral nitrates in coronary artery disease. Appropriateness and cost considerationsH Reuveni, E E Aviram, A Elhayani, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Antiviral Therapy|July 1, 1997
Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion StudyG Rezza, N Galai, P Pezzotti, et al.
BMJ (Clinical Research Ed.)|September 7, 1996
Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study GroupP Pezzotti, A N Phillips, M Dorrucci, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
An evaluation of assumptions underlying respondent-driven sampling and the social contexts of sexual and gender minority youth participating in HIV clinical trials in the United StatesA L Wirtz, J Iyer, D Brooks, et al.
Neurology|January 1, 1997
HIV infection and cognition in intravenous drug users: long-term follow-upO A Selnes, N Galai, J C McArthur, et al.
Archives of Internal Medicine|October 23, 1995
Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infectionW T Caiaffa, N M Graham, N Galai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 20, 2007
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panelsB Sarov, L Novack, N Galai, et al.
Addiction (Abingdon, England)|May 17, 2007
Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug usersD Vlahov, P O'Driscoll, S H Mehta, et al.
Archives of Internal Medicine|June 14, 2001
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspectiveS A Strathdee, N Galai, M Safaiean, et al.
Sidahora : Un Proyecto Del Departamento De Publicaciones Del PWA Coalition, NY|October 30, 2001
[The difference between men and women drug users in seroconversion risk factors]S A Strathdee, N Galai, M Safaiean, et al.
European Journal of Clinical Pharmacology|January 5, 2002
The prescription pattern of oral nitrates in coronary artery disease. Appropriateness and cost considerationsH Reuveni, E E Aviram, A Elhayani, et al.
Pageof 6